QuorumCivic. Hidden in plain sight Get the app
Bill intelligence
Full Simple

Congress clarifies: federal grants can now buy drug-checking test strips

H.R. 11045 — Preventing Overdoses with Test Strips Act · Filed by Josh Gottheimer (D-NJ) · 2 cosponsors · Introduced Nov 17, 2026 · Referred to committee

95%
Transparency
Typical bill: 85%
5/100
Hidden-provision risk
Typical bill: 15/100
Harm-Reduction Public Health Clarification

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill amends two federal health laws to explicitly allow grant money to be spent on fentanyl and xylazine test strips and similar detection devices. Currently, grants under these programs may not clearly cover such expenses; the bill removes that ambiguity, enabling public health agencies and substance-abuse programs to use federal funds to purchase and distribute test strips that let people check drugs for deadly adulterants before use.

Why we flagged it

The bill is a straightforward amendment to existing grant-program statutes to explicitly authorize spending on drug-checking test strips. It is not a new program, appropriation, or regulatory regime—merely a clarification that existing harm-reduction funds can be used for this evidence-based intervention.

What the text implies

  • Clarification may unlock existing grant funds already appropriated but previously unusable for test strips, effectively redirecting money without new appropriation.
  • Bill does not appropriate new funds; effectiveness depends on whether agencies prioritize test strips within existing budgets, creating potential for uneven implementation across states and programs.
  • Test-strip access may reduce emergency-department overdose presentations, lowering acute-care costs, but bill contains no mechanism to track or measure that public-health return.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to a low-cost, evidence-based harm-reduction tool (drug-checking test strips) that reduces overdose risk. No restrictions on citizens' rights or remedies are imposed; the bill simply clarifies that federal grant money can be used for a public-health intervention that saves lives.

Who stands to gain

  • test-strip manufacturers and distributors
  • substance-abuse treatment and harm-reduction nonprofits (as grant recipients)

Named in the bill

21st Century Cures Act, Public Health Service Act, Substance Abuse and Mental Health Services Administration (SAMHSA), fentanyl, xylazine

Where it stands

2 cosponsors: 2 Republicans.

  • Nov 17, 2026 — Introduced · Congress.gov: “Introduced in House”
  • Nov 17, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (1,916 characters) on Nov 19, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

As of — page rendered 2026-11-22.

“Congress clarifies: federal grants can now buy drug-checking test strips” QuorumCivic. https://share.quorumcivic.app/bill/119/hr11045 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.